热门资讯> 正文
Avenue Therapeutics申请出售142万股股票
2024-05-07 03:14
- Avenue Therapeutics (NASDAQ:ATXI) has filed a prospectus related to the resale of 1.42M shares of common stock.
- The shares are set to be issued in three tranches, comprised of 689,680 series C warrant shares, 689,680 series D warrant shares, and 41,381 placement agent warrant shares.
- The preliminary prospectus is not an offer to sell the securities.
- FORM S-3
More on Avenue Therapeutics
- Avenue Therapeutics drops 9% on 1-for-75 reverse split
- Avenue Therapeutics granted extension for Nasdaq compliance
- Seeking Alpha’s Quant Rating on Avenue Therapeutics
- Historical earnings data for Avenue Therapeutics
- Financial information for Avenue Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
